{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:19:16Z","timestamp":1792451956209,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.bmc.2017.06.051","type":"journal-article","created":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T20:02:05Z","timestamp":1498939325000},"page":"4526-4531","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Bistacrines as potential antitrypanosomal agents"],"prefix":"10.1016","volume":"25","author":[{"given":"Ines","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"G\u00f6llner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antje","family":"Fu\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"August","family":"Stich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kucharski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Schirmeister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Katzowitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike","family":"Bruhn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Miliu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Luise","family":"Krauth-Siegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Holzgrabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2017.06.051_b0005","unstructured":"World Health Organisation: Trypanosomiasis, fact sheet N\u00b0259. http:\/\/www.who.int\/mediacentre\/factsheets\/fs259\/en\/; Accessed 23.04.2015."},{"key":"10.1016\/j.bmc.2017.06.051_b0010","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.4155\/fmc.13.162","article-title":"Drug Discovery and human African trypanosomiasis: a disease less neglected?","volume":"5","author":"Ferrins","year":"2013","journal-title":"Future Med Chem"},{"key":"10.1016\/j.bmc.2017.06.051_b0015","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S1473-3099(13)70191-9","article-title":"Do we need new drugs against Human African Trypanosomiasis?","volume":"13","author":"Stich","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bmc.2017.06.051_b0020","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.1016\/j.bmc.2016.06.003","article-title":"Bistacrine derivatives as new potent antimalarials","volume":"24","author":"Schmidt","year":"2016","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2017.06.051_b0025","doi-asserted-by":"crossref","first-page":"25697","DOI":"10.1074\/jbc.M109.014340","article-title":"Vinyl Sulfones as Antiparasitic Agents and a Structural Basis for Drug Design","volume":"284","author":"Kerr","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2017.06.051_b0030","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.2174\/1389557515666160509125243","article-title":"The inhibition of cysteine proteases rhodesain and TbCatB: a valuable approach to treat human african trypanosomiasis","volume":"16","author":"Ettari","year":"2016","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.bmc.2017.06.051_b0035","doi-asserted-by":"crossref","first-page":"5156","DOI":"10.1016\/j.bmc.2015.01.031","article-title":"Synthesis, biological profiling and mechanistic studies of 4-aminoquinoline-based heterodimeric compounds with dual trypanocidal-antiplasmodial activity","volume":"23","author":"Sola","year":"2015","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2017.06.051_b0040","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1021\/jm960814j","article-title":"Phenothiazine inhibitors of trypanothione reductase as potential antitrypanosomal and antileishmanial drugs","volume":"41","author":"Chan","year":"1998","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2017.06.051_b0045","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0960-894X(00)00154-2","article-title":"Synthesis and evaluation of 9,9-dimethylxanthene tricyclics against Trypanothione Reductase, Trypanosoma brucei, Trypanosoma cruzi and Leishmania donovani","volume":"10","author":"Chibale","year":"2000","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2017.06.051_b0050","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1128\/AAC.01418-06","article-title":"Bis-acridines as lead antiparasitic agents: structure-activity analysis of a discrete compound library in vitro","volume":"51","author":"Caffrey","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2017.06.051_b0055","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.molbiopara.2015.11.003","article-title":"Thiol redox biology of trypanosomatids and potential targets for chemotherapy","volume":"206","author":"Leroux","year":"2016","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.bmc.2017.06.051_b0060","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0001-706X(97)00079-X","article-title":"The Alamar Blue\u00ae assay to determine drug sensitivity of African trypanosomes (T.b. rhodesiense and T.b. gambiense) in vitro","volume":"68","author":"R\u00e4z","year":"1997","journal-title":"Acta Trop"},{"key":"10.1016\/j.bmc.2017.06.051_b0065","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0022-1759(94)90396-4","article-title":"A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphoctes: an alternative to [3H]thymidine incorporation assay","volume":"170","author":"Ahmed","year":"1994","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.bmc.2017.06.051_b0070","doi-asserted-by":"crossref","first-page":"7053","DOI":"10.1016\/j.bmc.2015.09.029","article-title":"Development of novel dipeptide-like rhodesain inhibitors containing the 3-bromoisoxazoline warhead in a constrained conformation","volume":"23","author":"Ettari","year":"2015","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2017.06.051_b0075","doi-asserted-by":"crossref","first-page":"e298","DOI":"10.1371\/journal.pntd.0000298","article-title":"RNA interference of Trypanosoma brucei cathepsin B and L affects disease progression in a mouse model","volume":"2","author":"Abdulla","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.bmc.2017.06.051_b0080","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1432-1033.1989.tb14643.x","article-title":"Trypanothione reductase from Trypanosoma cruzi. Catalytic properties of the enzyme and inhibition studies with trypanocidal compounds","volume":"180","author":"Jockers-Scher\u00fcbl","year":"1989","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.bmc.2017.06.051_b0085","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.bbagen.2008.03.006","article-title":"Redox control in trypanosomatids, parasitic protozoa with trypanothione-based thiol metabolism","volume":"1780","author":"Krauth-Siegel","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bmc.2017.06.051_b0090","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nrd2445","article-title":"The influence of drug-like concepts on decision-making in medicinal chemistry","volume":"6","author":"Leeson","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmc.2017.06.051_b0095","unstructured":"Lee TBK. Method for the preparation of 9-amino-1,2,3,4-tetrahydroacridine. EU Patent 0500006A1, 1992."},{"key":"10.1016\/j.bmc.2017.06.051_b0100","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejmech.2003.10.003","article-title":"Tetrahydroacridin-9-ones, 9-chlorotetrahydroacridines, 9-amino-tetrahydroacridines and 9-(pyrazol-1-yl)-tetrahydroacridines derived from chiral cyclanones","volume":"39","author":"Frideling","year":"2004","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2017.06.051_b0105","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1021\/jm990971t","article-title":"SAR of 9-Amino-1,2,3,4-tetrahydroacridine-Based Acetylcholinesterase Inhibitors: Synthesis, Enzyme Inhibitory Activity, QSAR, and Structure-Based CoMFA of Tacrine Analogues","volume":"43","author":"Recanatini","year":"2000","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2017.06.051_b0110","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/jhet.5570430332","article-title":"Novel synthesis of 2H-3,1-benzoxazine derivatives","volume":"43","author":"Li","year":"2006","journal-title":"J. Heterocyclic Chem."},{"key":"10.1016\/j.bmc.2017.06.051_b0115","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0968-0896(98)00213-2","article-title":"Evaluation of short-tether bis-THA AChE inhibitors. A further test of the dual binding site hypothesis","volume":"7","author":"Carlier","year":"1999","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2017.06.051_b0120","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1021\/jm010308g","article-title":"Homodimeric tacrine congeners as acetylcholinesterase inhibitors","volume":"45","author":"Hu","year":"2002","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2017.06.051_b0125","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1211\/0022357011775046","article-title":"Synthesis and in-vitro anticancer evaluation of bistacrine congeners","volume":"53","author":"Hu","year":"2001","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.bmc.2017.06.051_b0130","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1021\/jm101439s","article-title":"Synthesis and structure-activity relationships of new quinolone-type molecules against Trypanosoma brucei","volume":"55","author":"Hiltensperger","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2017.06.051_b0135","doi-asserted-by":"crossref","first-page":"8332","DOI":"10.1021\/jacs.6b03052","article-title":"Quantum chemical-based protocol for the rational design of covalent inhibitors","volume":"138","author":"Schirmeister","year":"2016","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2017.06.051_b0140","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.ijpara.2009.05.002","article-title":"Preparative enzymatic synthesis of trypanothione and trypanothione analogues","volume":"39","author":"Comini","year":"2009","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.bmc.2017.06.051_b0145","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1432-1033.1984.tb07925.x","article-title":"Interaction of a glutathione S-conjugate with glutathione reductase Kinetic and X-ray crystallographic studies","volume":"138","author":"Bilzer","year":"1984","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.bmc.2017.06.051_b0150","doi-asserted-by":"crossref","first-page":"6218","DOI":"10.1016\/j.bmcl.2009.08.098","article-title":"Novel non-peptidic vinylsulfones targeting the S2 and S3 subsites of parasite cysteine proteases","volume":"19","author":"Bryant","year":"2009","journal-title":"Bioorg Med Chem Lett"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089617302262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089617302262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:50:35Z","timestamp":1760835035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089617302262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":30,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0968089617302262"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2017.06.051","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bistacrines as potential antitrypanosomal agents","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2017.06.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}